#regulation

The Trump administration has released rules for new Medicaid work requirements, with states moving quickly to implement them before next year.

A court ruling on whether partial foot movement counts as pedaling could influence how e-bike use is interpreted in legal and regulatory disputes.

Environmental advocates are pushing back against proposed Trump administration changes that would loosen federal coal ash monitoring and enforcement requirements.

The U.S. Securities and Exchange Commission has formally proposed rescinding its 2024 climate disclosure rule, reopening a fight over how much standardized climate-risk data public companies must provide to investors.

The measure would require frontier AI labs to undergo independent audits of whether they are following their own safety commitments, rather than relying solely on self-reporting.

A push in New York to tighten e-bike rules, including possible registration and licensing, appears to have stalled after gaining traction earlier this year.

The US National Transportation Safety Board has halted release of some previously public investigative materials after people used docket records to generate AI audio mimicking the final moments of a deadly flight.

Minnesota has enacted what appears to be the first outright state ban on prediction markets, and the CFTC has already sued to block it, arguing federal law gives the agency exclusive authority over the markets.

The U.S. EPA says it wants to rescind limits for four PFAS chemicals and delay enforcement for two others, reopening a major regulatory battle over so-called forever chemicals in drinking water.

According to reporting based on leaked and anonymously sourced details, a draft Trump administration executive order on frontier AI would let model developers choose whether to submit systems for government vetting, a ma

A coalition led by Humans First is urging President Donald Trump to require pre-release safety testing and government audits for frontier AI systems, signaling a notable shift in the politics of AI oversight.

STAT reports that acting FDA drug center head Tracy Beth Høeg is leaving the agency, widening a leadership vacuum that followed Commissioner Marty Makary’s resignation.

Endpoints News identified Marty Makary’s resignation as the week’s biggest health story, underscoring how quickly leadership changes at the FDA can dominate the sector’s outlook.

As hospitals deploy AI scribes and other clinical software at speed, a policy push to relax oversight is running into a practical problem: many of the tools still need human correction.

Multiple reports say FDA Commissioner Marty Makary is expected to be fired, though the plans were described as not yet final. The prospect of a sudden leadership change is drawing attention to how quickly political moves

A fast-growing market for conversational toys is raising fresh concerns about safety, privacy, and how always-on AI companions could shape childhood.

The FDA is rolling out a framework that could allow certain individualized gene therapies to reach patients with rare genetic disorders without human clinical trials, accelerating access while raising serious safety and信

Connected toys powered by large language models are rapidly entering the children’s market, but recent tests and early research suggest regulation has not kept pace with the risks.

A federal appeals court has struck down the FCC’s broadband anti-discrimination rules, narrowing the agency’s ability to police unequal internet access unless it can prove intentional bias.

The FDA is reconsidering Ebvallo after a prior rejection, following an agreement with the companies developing the treatment to address the agency’s main concern.